InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA (miRNA)-based therapeutics for cancer, announced that it was awarded an Innovation Credit of EUR 1.3 million from the Dutch government. This award will support the development of miRNA-based therapeutics...